The Durban Declaration

Illustration: A. Canamucio The 13th International AIDS Conference opened with a rousing call to "Break the Silence." Individuals, communities, and governments were implored to engage openly in dialogues on HIV and AIDS. Looming in the background was a hastily crafted Durban Declaration [DD] asserting, without proof, that HIV is the sole cause of AIDS.1 This factually is incorrect.2 Scientists, including an "AIDS-industrial complex," now are challenged to break all silence, end all blaming, and e

Written byRoulette Wm
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Illustration: A. Canamucio The 13th International AIDS Conference opened with a rousing call to "Break the Silence." Individuals, communities, and governments were implored to engage openly in dialogues on HIV and AIDS. Looming in the background was a hastily crafted Durban Declaration [DD] asserting, without proof, that HIV is the sole cause of AIDS.1 This factually is incorrect.2 Scientists, including an "AIDS-industrial complex," now are challenged to break all silence, end all blaming, and expose the ongoing denial of important scientific principles. Arrogance, smugness, and internecine acts must cease. Improved scholarship, especially regarding "slow virology," is essential. Truth and reconciliation are needed, along with moral leadership of the sort exhibited by Archbishop Desmond Tutu and President Nelson Mandela after apartheid ended in South Africa. Although challenging to implement, moral leadership must address costs to the infected, affected, and the infirm, and the consequences of the DD and "dissident" dogmas on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies